Progressive Multifocal Leukoencephalopathy
📧 Sign up to get email alerts when something new happens for Progressive Multifocal Leukoencephalopathy.
Sign up freeTop drugs studied for this disease
-
EMA safety_alert · 2010-01-21European Medicines Agency recommends additional measures to better manage risk of progressive multifocal leukoencephalopathy (PML) with Tysabri
EU regulators recommend extra measures to better manage the risk of progressive multifocal leukoencephalopathy (PML) with Tysabri (natalizum…
-
EMA safety_alert · 2008-08-13European Medicines Agency update on progressive multifocal leukoencephalopathy (PML) and Tysabri
EMA release updating on the risk of progressive multifocal leukoencephalopathy (PML) with natalizumab (Tysabri).